Glucose uptake in the heart is mediated by specific glucose transporters (GLUTs) present on cardiomyocyte cell surface membranes. Metabolic stress and insulin both increase glucose transport by stimulating the translocation of glucose transporters from intracellular storage vesicles to the cell surface. Isolated perfused transgenic mouse hearts are commonly used to investigate the molecular regulation of heart metabolism, however, current methods to quantify cell-surface glucose transporter content in intact mouse hearts are limited. Therefore, we developed a novel technique to directly assess the cell-surface content of the cardiomyocyte glucose transporter GLUT4 in perfused mouse hearts, using a cell-surface impermeant biotinylated bis-glucose photolabeling reagent (bio-LC-ATB-BGPA). Bio-LC-ATB-BGPA was infused through the aorta and cross-linked to cell-surface GLUTs. Bio-LC-ATB-BGPA-labeled GLUT4 was recovered from cardiac membranes by streptavidin-isolation and quantified by immunoblotting.
Introduction
One or more of the 13 transmembrane glucose transporter family of proteins (GLUTs) mediate glucose uptake in mammalian cells (22) . Glucose transport in the heart is rapidly activated by insulin (14) , exercise (8, 15) , hypoxia (40) and ischemia (47) , conditions under which glucose is an important cardiac substrate. Cardiac glucose uptake and glycolysis are protective in the ischemic heart (30) , and glucose transporter deficiency decreases ischemic tolerance(42).
In the heart, as in all striated muscles, myocyte glucose transport relies to a large extent on GLUT4, which when present in cell surface membranes, facilitates the entry of extracellular glucose. GLUT4, typically considered the insulin-responsive glucose transporter, is highly expressed in the heart (21) , particularly in cardiomyocytes (39, 47) .
Heart GLUT4 is stored in intracellular vesicles and translocates to cell surface membranes, including the sarcolemma and t-tubules following insulin, exercise, and ischemia (8, 14, 35, 38, 45) . GLUT4 is thought to be primarily responsible for the increase in glucose uptake in response to insulin and ischemic stress (35, 40, 42, 47) .
GLUT1 is also expressed in the heart, both in cardiac myocytes where it appears to have a role in basal glucose uptake (14, 37, 47) and more ubiquitously in endothelial cells(34). GLUT1 undergoes modest translocation to the sarcolemma with insulin and ischemia (14, 47) , as it does in adipocytes (46) . GLUT1 is also regulated at the expression level during ischemia, in part through the action of the transcription factor HIF1-alpha (19) . In addition to GLUT1 and GLUT4, novel glucose transporters such as GLUT8(6, 10) and GLUT12 (33) are expressed in the heart, although their physiologic roles are uncertain.
The ability to quantify cell surface GLUT4 is critical to understanding heart metabolism. In recent years, transgenic mice have provided important insights into the molecular mechanisms regulating the physiologic response of the heart to ischemia, pressure overload and diabetes (1) . While many techniques have been adapted to study mouse cardiac physiology and metabolism (4, 32) , the quantification of cell surface glucose transporters has proven challenging. Mouse hearts typically weigh only 150 mg, limiting the application of conventional membrane fractionation techniques that were developed for other species (13, 47) . Immunohistochemical and immunofluorescence techniques(38, 47) require less tissue, but the results are difficult to quantify. In addition, glucose transport activity requires translocation, docking and fusion of GLUT4 vesicles with the surface membrane (7, 20) and histological techniques often do not clearly discriminate between GLUT4 vesicles associated with surface membranes and active cell surface GLUT4.
Therefore, we sought to develop a new method to assess cell surface glucose transporters directly in the isolated perfused mouse heart. We used a cell-surface impermeant biotinylated bis-glucose photolabeling compound, 4,
Bis-mannose and bis-glucose reagents have proven useful in assessing cell-surface glucose transporters in isolated cells (14, 24) , as well as in excised cardiac (25) and skeletal muscles(36). Thus, isolated mouse hearts were retrogradely perfused for physiologic study, prior to bio-LC-ATB-BGPA infusion through the aortic cannula. The hearts underwent UV irradiation to cross-link the photo-activated diazirine group(17) to glucose transport proteins. Photolabeled cell-surface glucose transporters were isolated from cell membranes using streptavidin-agarose and then were quantified by immunoblotting with specific GLUT antibodies.
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Material and Methods
Animals
Wild-type C57/BL6 male mice (age 10-16 weeks) were used for all experiments.
Animals were housed in accordance with guidelines from the American Association for Laboratory Animal Care, fed a standard rodent chow diet with access to water ad libitum.
All procedures were approved by the Yale University Animal Care and Use Committee.
Perfusion Protocols
Hearts were isolated from anesthetized mice after the intra-peritoneal injection of heparin sulfate (100U) and pentobarbital sodium (100mg/kg). Hearts were perfused in the Langendorff mode with Krebs-Henseleit Buffer (KHB) containing 118mM NaCl, 4.75mM KCl, 1.2mMKH 2 PO 4 , 1.2mM MgSO 4 , 25mM NaHCO 3 , 7mM glucose, and 0.4mM oleate bound to 1% BSA. Hearts were perfused with a constant coronary flow of 4ml/min to eliminate potentially confounding vasodilatory effects of insulin on the delivery of the photolabel to the myocardium. To assess the effects of insulin, the perfusion protocol included an initial 30-minute perfusion without insulin, followed by an additional 35 minutes with or without 100µU/ml (0.7 nM) insulin.
Bio-LC-ATB-BGPA Photolabeling
Following completion of heart perfusion, the aortic cannula was flushed with 1 ml of icecold glucose-free KHB, followed by 1 ml of the same buffer containing various concentrations of bio-LC-ATB-BGPA. The infused bio-LC-ATB-BGPA was allowed 15 minutes to bind in the heart at 4 0 C. To improve exposure of the ventricular cavities to UV irradiation, the left ventricle (LV) and right ventricle (RV) cavities were opened sagitally and then the bound bio-LC-ATB-BGPA was photochemically cross-linked to cell-surface GLUTs on ice using a Rayonet photochemical reactor (340nm, 3 min each on the epicardial and endocardial surfaces; Southern New England Ultraviolet, Branford, CT). Hearts were freeze-clamped and stored in liquid nitrogen until further analysis. In experiments designed to study the specificity of bio-LC-ATB-BGPA binding, D-glucose (0, 10 or 20mM) was added to both the washout and bio-LC-ATB-BGPA buffers. In experiments assessing the homogeneity of bio-LC-ATB-BGPA delivery to different regions of the heart, the LV, RV and intraventricular septum were dissected apart after completion of cross-linking, prior to freezing the tissues.
Bio-LC-ATB-BGPA-labeled GLUT isolation
Approximately 50-100mg of myocardial tissue was homogenized in 400µl HEPES-EDTA-sucrose (HES) buffer (20mM HEPES, 5mM NaEDTA, 255mM sucrose, 1µg/l antipain, aprotinin, pepstatin, leupeptin, 100µM AEBSF [4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride], pH 7.2). Total cell membranes were isolated by ultracentrifugation (227,000g for 50 minutes at 4ºC) and resuspended in phosphate buffered saline containing 2% Thesit. Insoluble cellular contents were removed by centrifugation at 20,000g for 30 minutes at 4ºC. The supernatant containing the cardiac cell membranes ("total membrane") was saved and its protein concentration was measured by the Bradford method (Bio-Red protein assay, Bio-Red, Hercules, CA). In order to isolate the photolabeled GLUTs, 500µg of total membrane protein was incubated with 100µL of streptavidin bound to 6% agarose beads (Pierce, Rockford, IL) overnight at 4°C. The supernatant of the streptavidin-agarose isolation, which contained nonphotolabeled transporters, was saved as the "unlabeled fraction". The steptavidin-agarose isolated or "labeled fraction" of GLUTs was washed extensively with phosphate buffered saline containing decreasing concentrations of Thesit (1%, 0.1%, 0%). The labeled GLUTs were then dissociated from the streptavidin by boiling in SDS-containing electrophoresis buffer for 30 minutes with the subsequent addition of 10% mercaptoethanol prior to to SDS-PAGE. Boiling longer than 30 minutes, or for a second time following storage at -80ºC, led to irreversible aggregation of GLUT4 in our samples and was avoided.
GLUT1 and GLUT4 Immunoprecipitation
In additional experiments, cardiac membranes (500 Ng protein) from photolabeled hearts were initially immunoprecipitated with isoform-specific GLUT antibodies bound to protein A/G beads (Amersham Inc, USA). Immunoprecipitation was performed overnight in buffer containing125 mM Tris, 1 mM EDTA, 1 mM EGTA, 250 mM mannitol, 50 mM sodium fluoride, 5 mM sodium pyrophosphate, 1 mM DTT, 1 mM benzamidine, 0.004% trypsin inhibitor, and 3 mM sodium azide, pH 7.5, at 4º C.
Immunoprecipitated GLUT4 or GLUT1 was isolated by low-speed centrifugation and extensively washed with buffer, prior to SDS-PAGE and immunoblotting as described below with HRP-strepatavidin. The supernatants of the immunoprecipitates were also analyzed by immunoblotting to confirm complete efficiency of the immunoprecipitation procedures.
Immunoblotting
Samples were diluted in SDS-containing sample buffer and subjected to SDS-PAGE using 10% NuPAGE Bis-Tris gels (Invitrogen, Carlsbad, CA) with MOPS buffer. 
Glucose uptake in perfused hearts
Rates of glucose uptake were measured from the production of 
Results
Bio-LC-ATB-BGPA photolabeling dose titration
In order to determine the concentration of bio-LC-ATB-BGPA required to optimally label cell-surface GLUT4 in isolated perfused mouse hearts, we varied bio-LC-ATB-BGPA concentrations (0-500µM) in the buffer. Prior to labeling, these hearts were perfused with a mixed substrate buffer containing 100µU/ml of insulin for 30 minutes in order to increase the cell-surface GLUT4 content. Cell-surface GLUT4 photolabeling was found to be maximal at a concentration of approximately 400µM (Figure 1) , which is consistent with the K i (~190uM) for the inhibition of glucose transport by bio-LC-ATB-BGPA and similar compounds in cardiomyocytes (14) and adipocytes (17) . This concentration of bio-LC-ATB-BGPA (400µM) was used for all subsequent photolabeling.
Efficiency and specificity of bio-LC-ATB-BGPA GLUT4 photolabeling and isolation
In order to confirm that retrograde infusion of bio-LC-ATB-BGPA into the aorta and the coronary circulation delivered the photolabel uniformly throughout the heart, we separated the LV free wall, RV and intraventricular septum. Similar labeling of cellsurface GLUT4 was observed in each of these myocardial regions (Figure 2A) .
In order to determine the efficiency of BGPA-labeled GLUT4 recovery, we compared the GLUT4 content in total cardiac membranes prepared by ultracentrifugation, with that in the streptavidin-isolated 'labeled' fraction and the poststreptavidin supernatant 'unlabeled' fraction. Comparable aliquots from each fraction were subjected to SDS-PAGE and quantified by densitometric analysis of GLUT4 immunoblots. Total membrane GLUT4 was fully accounted for (99.6 ± 3.6%) by the sum of the 'labeled' and 'unlabeled' GLUT4 ( Figure 2B ). To further assess the efficiency of the isolation procedures, the membrane proteins were also blotted with HRP-streptavidin. These blots revealed a biotin-containing protein band at a molecular weight of approximately 50kD, representing the bio-LC-ATB-BGPA-glucose transporter conjugate, in both the total membrane and streptavidin-isolated fractions, but no residual BGPA-GLUT4 in the streptavidin supernatant fraction ( Figure 2B ). Taken together, these results provide evidence that the recovery of bio-LC-ATB-BGPA photolabeled GLUT4 was efficient. In addition, in order to exclude the possibility that the streptavidin isolation might non-specifically recover other high-abundance cell-surface membrane transport proteins, we immunoblotted the streptavidin isolates for Na 
Stimulation of GLUT translocation by insulin: Quantification of cell-surface GLUT by bio-LC-ATB-BGPA GLUT4 photolabeling
Insulin is the prototypical stimulus for heart GLUT4 translocation to the cell-surface (12, 14, 21, 35, 38, 45) . Therefore, we assessed whether bio-LC-ATB-BGPA photolabeling could effectively detect changes in cell-surface GLUTs after insulin stimulation in the isolated perfused mouse heart. In these experiments, bio-LC-ATB-BGPA-labeled cellsurface GLUT4 was compared in control and insulin-stimulated hearts ( Figure 3A) .
Hearts perfused with physiologic concentrations of insulin (100uU/ml), had a 3-4-fold greater cell-surface GLUT4 compared to control hearts (P<0.01) (Figure 3B ). During the same perfusions, glucose uptake measured by the production of Figure   3C ). Heart GLUT1 cell-surface labeling with bio-LC-ATB-BGPA GLUT1 is expressed in cardiomyocytes (13, 39, 49 ) and endothelial cells (34). GLUT1 is generally considered to be primarily involved in basal heart glucose transport, but also undergoes translocation to plasma membranes in response to insulin (14, 47) . We also analyzed the cell-surface labeling of GLUT 1 in intact hearts, after the infusion of bio-LC-ATB-BGPA. GLUT1 was present on cell-surface membranes in control mouse hearts and the content of labeled GLUT1 increased modestly (1.5-fold, P=0.05) in response to insulin (Figure 4A) . In order to examine the relative amount of cell-surface GLUT4 and GLUT1, an additional strategy was developed in which cell membranes from photolabeled hearts were immunoprecipitated with either GLUT4 or GLUT1
antibodies, submitted to SDS-PAGE and then probed with HRP-streptavidin. Assuming equal efficiency of GLUT1 and GLUT4 labeling using this approach, GLUT4 accounted for 43 ± 6% of total labeled GLUTs after insulin stimulation ( Figure 4B ).
Discussion
New methods to quantify cell-surface GLUT4 content in the mouse heart are needed to advance our understanding of myocardial glucose utilization in physiologic and important pathologic states, such as ischemic preconditioning (29, 44), ischemiareperfusion (34), insulin-resistance(3) and heart failure (5). Established methods are available in the isolated perfused mouse heart to measure rates of glucose uptake and phosphorylation with 2- (28) . The photolabeling technique complements these methods and provides a direct and easily quantifiable measure of cell-surface GLUT4, which may prove useful in studying glucose transport regulation in the isolated perfused mouse heart.
The isolated heart has advantages over excised heart muscles (25) for the study of glucose transport regulation, because it is an intact, contracting, and more physiologic preparation. We devised an infusion technique, which produced homogenous photolabeling of cell-surface GLUT4 throughout different regions of the intact perfused heart. This might also prove important in terms of studying pathologic processes that involve specific regions of the heart. Successful implementation of this approach required technical considerations that warrant emphasis. Effective perfusion of both the left and right coronary arteries required that the aortic cannula be placed above the aortic valve and the coronary artery ostia. This was facilitated by cutting the aorta just prior to the innominate artery during cardiac excision, to allow an adequate aortic length for cannulation. Heparin administration to the mouse prior to heart excision was needed to prevent coronary microthrombi that might otherwise interfere with the uniform delivery of the infused photolabel. Finally, meticulous attention was required to avoid the introduction of air bubbles into the aortic cannula, when the heart was removed from the perfusion apparatus and connected to the syringe containing the photolabel.
The concentrations of bio-LC-ATB-BGPA that saturated GLUT4 labeling in our experiments (400µM) are very similar to those observed in isolated rat adipocytes (300-500µM) (18, 27) . GLUT4 labeling was not only dose-dependent, but also competitively inhibited by the addition of glucose to the photolabeling buffer. The specificity of the technique was further supported by the absence of a high abundance cell-surface protein ( 1 Na + /K + ATPase) in the streptavidin isolates. In addition, it would appear unlikely that there was significant labeling of intracellular GLUT4, because of the cell-impermeant nature of bio-LC-ATB-BGPA compound (17) , and the finding that only 15% of GLUT4 was present on the cell-surface in the absence of insulin, which is quite similar to previous reports based on membrane fractionation in rat and canine hearts(43, 47).
The biotin-containing compound bio-LC-ATB-BGPA has significant technical advantages over tritiated photolabeling reagents (14, 18) for assessing cell surface GLUT4 in the heart. The use of the biotin compound avoids the radioactivity containment challenges that would be associated with the use of tritiated compounds in intact hearts.
It also allows for cell-surface GLUT4 quantification without the need to excise the photolabeled glucose transporters from SDS-PAGE gels for scintillation counting. The highly efficient recovery of cell-surface labeled GLUT4 with streptavidin-agarose can be attributed to both the high affinity of the biotin-streptavidin interaction and the long side chain design of bio-LC-ATB-BGPA that makes the biotin moiety readily accessible (17) .
Once cell-surface labeled GLUT4 is separated from other GLUT4 protein, immunoblotting techniques are highly specific for GLUT transporters. Therefore, the use of the biotinylated compound provides an effective measure of cell surface GLUT4 in the perfused heart. GLUT4 translocation to the cell surface is the principal component of the cardiomyocyte response to insulin (12, 14, 35, 45) . Thus, as proof of principle, we assessed the ability of the BGPA infusion method to measure changes in cell-surface GLUT4 content in response to a physiologic concentration of insulin (100 µU/ml).
Insulin increased cell-surface GLUT4 content 3-4-fold, which was consistent with the increased in glucose uptake observed in this and previous studies of perfused mouse hearts (2, 26) . The magnitude of insulin-stimulation in contracting hearts is less than that observed in isolated non-contracting cardiac myocytes(3), highlighting the importance of studying the heart under these more physiologic conditions. One limitation of this method is that it does not differentiate between cell surface GLUT4 in sarcolemma and ttubule membranes. However, given the size of bio-LC-ATB-BGPA compound, it is unlikely to be excluded from the t-tubule space, and tritiated-BMPA is known to label ttubules in skeletal muscle (11) .
The high efficiency of GLUT4 labeling observed in the perfused hearts confirms that bio-LC-ATB-BGPA delivered via aortic perfusion was readily able to reach cardiomyocytes, since the heart contains little or no non-cardiomyocyte GLUT4. Aortic smooth muscle cells also express GLUT4(23, 31), but GLUT4 does not appear to be present in heart blood vessels (9, 49) . Although infusion of photolabel leads to initial contact with capillary endothelium, endothelial cells do not express GLUT4 transporters (41) .
The photolabel technique also shows that the heart contains a significant amount of cell surface GLUT1, consistent with prior reports (13, 47) . GLUT1 is highly expressed in endothelial cells(34, 36) and a recent immuno-gold electron microscopy study demonstrated greater GLUT1 expression in endothelial cells than in cardiomyocytes in the adult rat heart(9). Our results indicate that insulin modestly increases cell surface GLUT1 in the heart, but do not elucidate which cell type might be insulin responsive.
Insulin increases cell surface GLUT1 in isolated cardiomyocytes (14) , but glucose uptake in endothelial cells is typically not responsive to insulin at physiologic concentrations, except when cultured in the presence of very high glucose concentrations(16). In addition, we found that insulin stimulation of heart glucose uptake paralleled the extent of increase in cell surface GLUT4, supporting the contention that GLUT4 is primarily responsible for insulin's effect, as suggested by studies in the GLUT4 knockout mouse (44) . Although GLUT1 may contribute to cardiomyocyte glucose transport (14) , our observations are also consistent with the hypothesis that a significant amount of heart GLUT1 functions as an endothelial transporter (9), which is not rate-limiting for insulinstimulation of total heart or cardiomyocyte glucose uptake. Our results also do not exclude the possibility that insulin directly activates either GLUT1 or GLUT4 in cardiomyocytes.
Additional glucose transporters, such as GLUT8(10) and GLUT12 (33) are also expressed in the heart, although their roles in mediating glucose transport remains uncertain. The photolabeling technique potentially could be used to assess the cell surface content of these novel glucose transporters and thus provide an indication of their function in the heart. Although we have been unable to detect these transporters on the cell-surface under control or insulin-stimulated conditions using the bio-LC-ATB-BGPA approach (E. Miller, K. Moley, S. Rogers, L. Young, unpublished data), it is possible that these novel glucose transporters may undergo translocation to the cell-surface under pathologic conditions or with other stimuli.
In conclusion, photolabeling with bio-LC-ATB-BGPA is a novel, efficient, and quantifiable method that can be used to assess cell-surface GLUT4 in the isolated perfused mouse heart. The infusion method may help to further elucidate the molecular mechanisms controlling GLUT4 translocation and the role of GLUT4 in the mouse heart under physiologic and pathophysiologic conditions. Although we assessed cell surface GLUTs in the heart, the approach is potentially also applicable more broadly to the investigation of additional cell-surface transporters in the heart and other perfused organs. Varying concentrations of bio-LC-ATB-BGPA (0-500µM) where used to label cellsurface GLUT4 in hearts (n=4) after 30 minute perfusions with insulin (100µU/ml).
Labeled GLUT4 was isolated from total heart membranes with streptavidin-agarose and then detected after SDS-PAGE by immunoblotting with GLUT4 antibody (top), quantified by densitometry, and expressed relative to total membrane GLUT4 (bottom). Mouse heart glucose transporter photolabeling, page 25
Detection of BGPA-labeled GLUT1 and GLUT4 using HRP-streptavidin. Total heart GLUT1 or GLUT4 was immunoprecipitated from membranes from control or insulinstimulated hearts. Immunoprecipitated proteins were subjected to SDS-PAGE, transferred to PVDF; the cell-surface biotin-tagged GLUTs were then detected using HRP-streptavidin and quantified by densitometry. Unlabeled 'UL' membrane proteins were prepared from perfused hearts that were not photolabeled and served as negative 
